Nebraska Cancer Specialists is proud to have the largest Research Department in the Midwest offering phase I through phase IV trials.

Refer a Patient

For more information or to refer a patient to the Legacy NCS program, please visit NebraskaCancer.com/Legacy or call Nebraska Cancer Specialists at 402.691.6971.

Phase I Clinical Trials at Nebraska Cancer Specialists

Phase I trials evaluate the safety of a new drug or a new combination of drugs. These trials involve a small number of patients for whom standard therapies have proven ineffective, and seek to determine a safe dose level and evaluate efficiency.

Our robust Research Department is helping advance cancer research, while offering hope to patients fighting their toughest battles. Through phase I trials, we are able offer first ever access to clinical trial treatments and therapies. Our research department has experience in delivering first-in-human drug trials including studies in which we have treated the first patient ever with new drugs.

When a patient is deemed eligible for a phase 1 trial, they experience an added level of care at Nebraska Cancer Specialists

In addition to our standard oncology team of physicians, nurse practitioners and case managers, patients in phase I trials will be working closely hand-in-hand with our Research Team.

Meet Our Dedicated Team

The Research team at NCS is a robust team of research nurses, assistants, pharmacy techs and data managers.

Dr Ralph Hauke Research Medical Director	Dr Sam Mehr Research Physician	Marlene Bridwell Clinical Research Nurse Coordinator
Megan Meays MAM, CCRC Research Director	Scott Degenhardt, NMAA, MIS Clinical Research Manager	Gladys Pierce RN,OCN Clinical Research Nurse Coordinator
Heather Cordes Clinical Research Coordinator	Josh Settlemire, RN, BSN, OCN Clinical Research Nurse Coordinator	Julie Ehlers, MS Clinical Research Coordinator